Physician profile
Alan Gray Busby
NPI 1760653331
$2,432.13
in general payments reported to CMS, 2019-2025
15 companies · $467 in 2025
The $467 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2020: $115 · 2021: $82.68 · 2022: $291 · 2023: $279 · 2024: $657 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,207 · Gift: $175 · Entertainment: $20.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,207.13 |
| Gift | $175.00 |
| Entertainment | $20.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $475.90 | 2022-2024 | Dailies Total1 |
| Maculogix, INC. | $352.26 | 2019-2020 | |
| Coopervision INC. | $336.31 | 2019-2025 | Misight Contact Lens |
| Lkc Technologies, INC. | $182.48 | 2023-2024 | |
| Visionary Optics LLC | $175.00 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $167.48 | 2025 | Xdemvy |
| Lumenis Be INC | $152.33 | 2022 | |
| Bausch & Lomb Americas INC. | $113.51 | 2024 | Envista Mx60 Iol |
| Glaukos Corporation | $111.10 | 2025 | Idosetr |
| Biotissue Holdings INC. | $107.14 | 2025 | |
| Topcon Healthcare, INC. | $106.66 | 2024 | |
| Visioneering Technologies, INC. | $95.57 | 2019 | |
| Optos, INC. | $20.69 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Kala Pharmaceuticals, INC. | $16.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Busby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.